GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Health Sciences Acquisitions Corp 2 (NAS:HSAQ) » Definitions » Cash-to-Debt

Health Sciences Acquisitions 2 (Health Sciences Acquisitions 2) Cash-to-Debt : No Debt (1) (As of Dec. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Health Sciences Acquisitions 2 Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Health Sciences Acquisitions 2's cash to debt ratio for the quarter that ended in Dec. 2022 was No Debt (1).

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Health Sciences Acquisitions 2 could pay off its debt using the cash in hand for the quarter that ended in Dec. 2022.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Health Sciences Acquisitions 2's Cash-to-Debt or its related term are showing as below:

HSAQ's Cash-to-Debt is not ranked *
in the Diversified Financial Services industry.
Industry Median: 3.34
* Ranked among companies with meaningful Cash-to-Debt only.

Health Sciences Acquisitions 2 Cash-to-Debt Historical Data

The historical data trend for Health Sciences Acquisitions 2's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Health Sciences Acquisitions 2 Cash-to-Debt Chart

Health Sciences Acquisitions 2 Annual Data
Trend Dec20 Dec21 Dec22
Cash-to-Debt
No Debt No Debt No Debt

Health Sciences Acquisitions 2 Quarterly Data
May20 Sep20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt No Debt

Competitive Comparison of Health Sciences Acquisitions 2's Cash-to-Debt

For the Shell Companies subindustry, Health Sciences Acquisitions 2's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Health Sciences Acquisitions 2's Cash-to-Debt Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Health Sciences Acquisitions 2's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Health Sciences Acquisitions 2's Cash-to-Debt falls into.


Health Sciences Acquisitions 2 Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Health Sciences Acquisitions 2's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Health Sciences Acquisitions 2 had no debt (1).

Health Sciences Acquisitions 2's Cash to Debt Ratio for the quarter that ended in Dec. 2022 is calculated as:

Health Sciences Acquisitions 2 had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Sciences Acquisitions 2  (NAS:HSAQ) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Health Sciences Acquisitions 2 Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Health Sciences Acquisitions 2's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Health Sciences Acquisitions 2 (Health Sciences Acquisitions 2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Health Sciences Acquisitions Corp 2 (NAS:HSAQ) » Definitions » Cash-to-Debt
Comparable Companies
SAMA AACI BSAQ RCAC LCAP GFOR CLBR NGC HLXA TCOA GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
40, 10th Avenue, Floor 7, New York, NY, USA, 10014
Website
Health Sciences Acquisitions Corp 2 is a blank check company.
Executives
Joshua Aiello officer: See Remarks 150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Eric S Fain director ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN MN
Yuval Mika officer: See Remarks 150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Jason Aryeh director 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
David P Hochman director, officer: See Remarks 15 WESTON HILL RD., RIVERSIDE CT 06878
Geoffrey Wade Smith director 6740 SHADY OAK ROAD, EDEN PRAIRIE MN 55344
Pamela Ann Connealy director 320 W 37TH STREET, 3RD FLOOR, NEW YORK NY 10016
Rose Eric A Md director 161 FORT WASHINGTON AVENUE, 7TH FLOOR, NEW YORK NY 10032
Plc Medtronic 10 percent owner 20 ON HATCH, LOWER HATCH STREET, DUBLIN L2 2
Michael Kaswan officer: Chief Financial Officer KBL HEALTHCARE ACQUISITION CORP II, 645 MADISON AVENUE, NEW YORK NY 10022
Darren Sherman director, officer: See Remarks C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Roderick Wong director, 10 percent owner, officer: Chief Executive Officer C/O RTW INVESTMENTS, LP, 40 10TH AVENUE, 7TH FLOOR, NEW YORK NY 10014
Rtw Investments, Lp 10 percent owner 40 10TH AVENUE, 7TH FLOOR, NEW YORK NY 10014
Hsac 2 Holdings, Llc 10 percent owner 412 WEST 15TH STREET, FLOOR 9, NEW YORK NY 10011
Stephanie A Sirota officer: VP-Corp Strategy & Corp Comms. 412 WEST 15TH STREET, FLOOR 9, NEW YORK NY 10011